Epithelial cells and innate antifungal defense

Journal of Dental Research

Volumn 89, Issue 7, 2010, Pages 666-675

  Weindl, G ^a   Wagener, J ^b   Schaller, M ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

C type lectin receptors; Candida albicans; Innate immunity; Oral epithelium; Toll like receptors

Indexed keywords

EID: 77953744556     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510368784     Document Type: Review

References (131)

1. Acosta-Rodriguez EV, Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., et al. (2007). Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8: 639-646.
2. Ali A., Natah S., Konttinen Y. (2008). Differential expression of Toll-like receptors in chronic hyperplastic candidosis. Oral Microbiol Immunol 23: 299-307.
3. Arendorf TM, Walker DM (1979). Oral candidal populations in health and disease. Br Dent J 147: 267-272.
4. Bahri R., Saidane-Mosbahi D., Rouabhia M. (2010). Candida famata modulates Toll-like receptor, beta-defensin, and proinflammatory cytokine expression by normal human epithelial cells. J Cell Physiol 222: 209-218.
5. Beklen A., Hukkanen M., Richardson R., Konttinen YT (2008). Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis. Oral Microbiol Immunol 23: 425-431.
6. Bellocchio S., Montagnoli C., Bozza S., Gaziano R., Rossi G., Mambula SS, et al. (2004). The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 172: 3059-3069.
7. Bozza S., Zelante T., Moretti S., Bonifazi P., DeLuca A., DAngelo C., et al. (2008). Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J Immunol 180: 4022-4031.
8. Brown GD (2006). Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6: 33-43.
9. Brown GD, Herre J., Williams DL, Willment JA, Marshall AS, Gordon S. (2003). Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 197: 1119-1124.
10. Bryant C., Fitzgerald KA (2009). Molecular mechanisms involved in inflammasome activation Trends Cell Biol 19: 455-464.
11. Bugarcic A., Hitchens K., Beckhouse AG, Wells CA, Ashman RB, Blanchard H. (2008). Human and mouse macrophage-inducible C-type lectin (Mincle) bind Candida albicans. Glycobiology 18: 679-685.
12. Calderone RA, Fonzi WA (2001). Virulence factors of Candida albicans. Trends Microbiol 9: 327-335.
13. Cambi A., Gijzen K., de Vries JM, Torensma R., Joosten B., Adema GJ, et al. (2003). The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur J Immunol 33: 532-538.
14. Cambi A., Netea MG, Mora-Montes HM, Gow NA, Hato SV, Lowman DW, et al. (2008). Dendritic cell interaction with Candida albicans critically depends on N-linked mannan. J Biol Chem 283: 20590-20599.
15. Clemons KV, Stevens DA (2001). Overview of host defense mechanisms in systemic mycoses and the basis for immunotherapy. Semin Respir Infect 16: 60-66.
16. Conti HR, Shen F., Nayyar N., Stocum E., Sun JN, Lindemann MJ, et al. (2009). Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206: 299-311.
17. Cutler CW, Jotwani R. (2006). Dendritic cells at the oral mucosal interface [review]. J Dent Res 85: 678-689.
18. De Luca A., Montagnoli C., Zelante T., Bonifazi P., Bozza S., Moretti S., et al. (2007). Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol 179: 5999-6008.
19. Diamond G., Beckloff N., Ryan LK (2008). Host defense peptides in the oral cavity and the lung: similarities and differences [review]. J Dent Res 87: 915-927.
20. Dillon S., Agrawal S., Banerjee K., Letterio J., Denning TL, Oswald-Richter K., et al. (2006). Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest 116: 916-928.
21. Dongari-Bagtzoglou A., Kashleva H. (2003). Granulocyte-macrophage colony-stimulating factor responses of oral epithelial cells to Candida albicans. Oral Microbiol Immunol 18: 165-170.
22. Dongari-Bagtzoglou A., Fidel PL Jr (2005). The host cytokine responses and protective immunity in oropharyngeal candidiasis [review]. J Dent Res 84: 966-977.
23. Dongari-Bagtzoglou A., Villar CC, Kashleva H. (2005). Candida albicans-infected oral epithelial cells augment the anti-fungal activity of human neutrophils in vitro. Med Mycol 43: 545-549.
24. Evans SE, Hahn PY, McCann F., Kottom TJ, Pavlovic ZV, Limper AH (2005). Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms. Am J Respir Cell Mol Biol 32: 490-497.
25. Eversole LR, Reichart PA, Ficarra G., Schmidt-Westhausen A., Romagnoli P., Pimpinelli N. (1997). Oral keratinocyte immune responses in HIVassociated candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84: 372-380.
26. Eyerich K., Foerster S., Rombold S., Seidl HP, Behrendt H., Hofmann H., et al. (2008). Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol 128: 2640-2645.
27. Feng Z., Jiang B., Chandra J., Ghannoum M., Nelson S., Weinberg A. (2005). Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res 84: 445-450.
28. Ferwerda B., Ferwerda G., Plantinga TS, Willment JA, van Spriel AB, Venselaar H., et al. (2009). Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361: 1760-1767.
29. Fidel PL Jr, Ginsburg KA, Cutright JL, Wolf NA, Leaman D., Dunlap K., et al. (1997). Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J Infect Dis 176: 728-739.
30. Filler SG, Yeaman MR, Sheppard D. (2005). Tumor necrosis factor inhibition and invasive fungal infections. Clin Infect Dis 41 (Suppl 3). 208-212.
31. Gaffen SL (2009). Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9: 556-567 ; erratum in Nat Rev Immunol 9: 747, 2009.
32. Gantner BN, Simmons RM, Canavera SJ, Akira S., Underhill DM (2003). Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 197: 1107-1117.
33. Gantner BN, Simmons RM, Underhill DM (2005). Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 24: 1277-1286.
34. Gil ML, Gozalbo D. (2009). Role of Toll-like receptors in systemic Candida albicans infections Front Biosci 14: 570-582.
35. Glocker EO, Hennigs A., Nabavi M., Schaffer AA, Woellner C., Salzer U., et al. (2009). A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361: 1727-1735.
36. Graham LM, Brown GD (2009). The Dectin-2 family of C-type lectins in immunity and homeostasis Cytokine 48: 148-155.
37. Gross O., Gewies A., Finger K., Schafer M., Sparwasser T., Peschel C., et al. (2006). Card9 controls a non-TLR signalling pathway for innate antifungal immunity. Nature 442: 651-656.
38. Gross O., Poeck H., Bscheider M., Dostert C., Hannesschlager N., Endres S., et al. (2009). Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459: 433-436.
39. Herre J., Marshall AS, Caron E., Edwards AD, Williams DL, Schweighoffer E., et al. (2004). Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 104: 4038-4045.
40. Hise AG, Tomalka J., Ganesan S., Patel K., Hall BA, Brown GD, et al. (2009). An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5: 487-497.
41. Huang W., Na L., Fidel PL, Schwarzenberger P. (2004). Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190: 624-631.
42. Janeway CA Jr, Medzhitov R. (2002). Innate immune recognition. Annu Rev Immunol 20: 197-216.
43. Joly S., Maze C., McCray PB Jr, Guthmiller JM (2004). Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 42: 1024-1029.
44. Joly S., Ma N., Sadler JJ, Soll DR, Cassel SL, Sutterwala FS (2009). Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J Immunol 183: 3578-3581.
45. Jouault T., Ibata-Ombetta S., Takeuchi O., Trinel PA, Sacchetti P., Lefebvre P., et al. (2003). Candida albicans phospholipomannan is sensed through Toll-like receptors. J Infect Dis 188: 165-172.
46. Kumar H., Kumagai Y., Tsuchida T., Koenig PA, Satoh T., Guo Z., et al. (2009). Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal beta-glucan. J Immunol 183: 8061-8067.
47. Kummer JA, Broekhuizen R., Everett H., Agostini L., Kuijk L., Martinon F., et al. (2007). Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem 55: 443-452.
48. Laube DM, Dongari-Bagtzoglou A., Kashleva H., Eskdale J., Gallagher G., Diamond G. (2008). Differential regulation of innate immune response genes in gingival epithelial cells stimulated with Aggregatibacter actinomycetemcomitans. J Periodontal Res 43: 116-123.
49. Le Cabec V., Emorine LJ, Toesca I., Cougoule C., Maridonneau-Parini I. (2005). The human macrophage mannose receptor is not a professional phagocytic receptor. J Leukoc Biol 77: 934-943.
50. Lee HM, Shin DM, Choi DK, Lee ZW, Kim KH, Yuk JM, et al. (2009 a). Innate immune responses to Mycobacterium ulcerans via Toll-like receptors and dectin-1 in human keratinocytes. Cell Microbiol 11: 678-692.
51. Lee HM, Yuk JM, Shin DM, Jo EK (2009 b). Dectin-1 is inducible and plays an essential role for mycobacteria-induced innate immune responses in airway epithelial cells. J Clin Immunol 29: 795-805.
52. Lee SJ, Zheng NY, Clavijo M., Nussenzweig MC (2003). Normal host defense during systemic candidiasis in mannose receptor-deficient mice. Infect Immun 71: 437-445.
53. Leibundgut-Landmann S., Gross O., Robinson MJ, Osorio F., Slack EC, Tsoni SV, et al. (2007). Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8: 630-638.
54. Li L., Dongari-Bagtzoglou A. (2009). Epithelial GM-CSF induction by Candida glabrata. J Dent Res 88: 746-751.
55. Li L., Redding S., Dongari-Bagtzoglou A. (2007). Candida glabrata: an emerging oral opportunistic pathogen [review]. J Dent Res 86: 204-215.
56. Li M., Chen Q., Shen Y., Liu W. (2009). Candida albicans phospholipomannan triggers inflammatory responses of human keratinocytes through Toll-like receptor 2 Exp Dermatol 18: 603-610.
57. Ma CS, Chew GY, Simpson N., Priyadarshi A., Wong M., Grimbacher B., et al. (2008). Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 205: 1551-1557.
58. Mahanonda R., Pichyangkul S. (2007). Toll-like receptors and their role in periodontal health and disease. Periodontol 2000 43: 41-55.
59. Martinon F., Mayor A., Tschopp J. (2009). The inflammasomes: guardians of the body. Annu Rev Immunol 27: 229-265.
60. McGreal EP, Rosas M., Brown GD, Zamze S., Wong SY, Gordon S., et al. (2006). The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology 16: 422-430.
61. McKenzie EJ, Taylor PR, Stillion RJ, Lucas AD, Harris J., Gordon S., et al. (2007). Mannose receptor expression and function define a new population of murine dendritic cells. J Immunol 178: 4975-4983.
62. Milner JD, Brenchley JM, Laurence A., Freeman AF, Hill BJ, Elias KM, et al. (2008). Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452: 773-776.
63. Miyazato A., Nakamura K., Yamamoto N., Mora-Montes HM, Tanaka M., Abe Y., et al. (2009). Toll-like receptor 9-dependent activation of myeloid dendritic cells by deoxynucleic acids from Candida albicans. Infect Immun 77: 3056-3064.
64. Mostefaoui Y., Claveau I., Rouabhia M. (2004). In vitro analyses of tissue structure and interleukin-1beta expression and production by human oral mucosa in response to Candida albicans infections. Cytokine 25: 162-171.
65. Netea MG, van Tits LJ, Curfs JH, Amiot F., Meis JF, van der Meer JW, et al. (1999). Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol 163: 1498-1505.
66. Netea MG, Sutmuller R., Hermann C., Van der Graaf CA, Van der Meer JW, van Krieken JH, et al. (2004). Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 172: 3712-3718.
67. Netea MG, Ferwerda G., van der Graaf CA, Van der Meer JW, Kullberg BJ (2006 a). Recognition of fungal pathogens by Toll-like receptors. Curr Pharm Des 12: 4195-4201.
68. Netea MG, Gow NA, Munro CA, Bates S., Collins C., Ferwerda G., et al. (2006 b). Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 116: 1642-1650.
69. Netea MG, Brown GD, Kullberg BJ, Gow NA (2008 a). An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 6: 67-78.
70. Netea MG, van de Veerdonk F., Verschueren I., van der Meer JW, Kullberg BJ (2008 b). Role of TLR1 and TLR6 in the host defense against disseminated candidiasis. FEMS Immunol Med Microbiol 52: 118-123.
71. Oppenheim FG, Xu T., McMillian FM, Levitz SM, Diamond RD, Offner GD, et al. (1988). Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem 263: 7472-7477.
72. Osorio F., Leibundgut-Landmann S., Lochner M., Lahl K., Sparwasser T., Eberl G., et al. (2008). DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 38: 3274-3281.
73. Pivarcsi A., Bodai L., Rethi B., Kenderessy-Szabo A., Koreck A., Szell M., et al. (2003). Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 15: 721-730.
74. Reid DM, Montoya M., Taylor PR, Borrow P., Gordon S., Brown GD, et al. (2004). Expression of the beta-glucan receptor, Dectin-1, on murine leukocytes in situ correlates with its function in pathogen recognition and reveals potential roles in leukocyte interactions. J Leukoc Biol 76: 86-94.
75. Rice PJ, Adams EL, Ozment-Skelton T., Gonzalez AJ, Goldman MP, Lockhart BE, et al. (2005). Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmacol Exp Ther 314: 1079-1086.
76. Roeder A., Kirschning CJ, Rupec RA, Schaller M., Weindl G., Korting HC (2004). Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol 42: 485-498. (Pubitemid 40109561)
77. Romani L. (1999). Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol 2: 363-367.
78. Rouabhia M., Ross G., Pagé N., Chakir J. (2002). Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation. Infect Immun 70: 7073-7080.
79. Ruhnke M. (2006). Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts. Current drug targets 7: 495-504.
80. Rupniak HT, Rowlatt C., Lane EB, Steele JG, Trejdosiewicz LK, Laskiewicz B., et al. (1985). Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck. J Natl Cancer Inst 75: 621-635.
81. Ryan KR, Hong M., Arkwright PD, Gennery AR, Costigan C., Dominguez M., et al. (2008). Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED. Clin Exp Immunol 154: 406-414.
82. Saijo S., Fujikado N., Furuta T., Chung S., Kotaki H., Seki K., et al. (2007). Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 8: 39-46.
83. Samaranayake LP, Keung Leung W., Jin L. (2009). Oral mucosal fungal infections. Periodontol 2000 49: 39-59.
84. Sato K., Yang XL, Yudate T., Chung JS, Wu J., Luby-Phelps K., et al. (2006). Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses. J Biol Chem 281: 38854-38866.
85. Savolainen J., Rantala A., Nermes M., Lehtonen L., Viander M. (1996). Enhanced IgE response to Candida albicans in postoperative invasive candidiasis. Clin Exp Allergy 26: 452-460.
86. Schaller M., Weindl G. (2009). Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia for the study of host-pathogen interactions. Methods Mol Biol 470: 327-345.
87. Schaller M., SchÄfer W., Korting HC, Hube B. (1998). Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol 29: 605-615.
88. Schaller M., Korting HC, SchÄfer W., Bastert J., Chen W., Hube B. (1999). Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol 34: 169-180.
89. Schaller M., Mailhammer R., Grassl G., Sander CA, Hube B., Korting HC (2002). Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol 118: 652-657.
90. Schaller M., Boeld U., Oberbauer S., Hamm G., Hube B., Korting HC (2004). Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. Microbiology 150 (Pt 9). 2807-2813.
91. Schaller M., Borelli C., Korting HC, Hube B. (2005). Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 48: 365-377.
92. Schaller M., Zakikhany K., Naglik JR, Weindl G., Hube B. (2006). Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia. Nat Protoc 1: 2767-2773.
93. Schneider JJ, Unholzer A., Schaller M., SchÄfer-Korting M., Korting HC (2005). Human defensins. J Mol Med 83: 587-595.
94. Sheikh F., Baurin VV, Lewis-Antes A., Shah NK, Smirnov SV, Anantha S., et al. (2004). Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J Immunol 172: 2006-2010.
95. Steubesand N., Kiehne K., Brunke G., Pahl R., Reiss K., Herzig KH, et al. (2009). The expression of the beta-defensins hBD-2 and hBD-3 is differentially regulated by NF-kappaB and MAPK/AP-1 pathways in an in vitro model of Candida esophagitis. BMC Immunol 10: 36.
96. Strober W. (2004). Epithelial cells pay a Toll for protection. Nat Med 10: 898-900.
97. Sugawara Y., Uehara A., Fujimoto Y., Kusumoto S., Fukase K., Shibata K., et al. (2006). Toll-like receptors, NOD1, and NOD2 in oral epithelial cells. J Dent Res 85: 524-529.
98. Sutmuller RP, den Brok MH, Kramer M., Bennink EJ, Toonen LW, Kullberg BJ, et al. (2006). Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 116: 485-494.
99. Szolnoky G., Bata-Csorgo Z., Kenderessy AS, Kiss M., Pivarcsi A., Novak Z., et al. (2001). A mannose-binding receptor is expressed on human keratinocytes and mediates killing of Candida albicans. J Invest Dermatol 117: 205-213.
100. Tachado SD, Zhang J., Zhu J., Patel N., Cushion M., Koziel H. (2007). Pneumocystis-mediated IL-8 release by macrophages requires coexpression of mannose receptors and TLR2. J Leukoc Biol 81: 205-211.
101. Takeda K., Kaisho T., Akira S. (2003). Toll-like receptors. Annu Rev Immunol 21: 335-376.
102. Tardif F., Goulet JP, Zakrazewski A., Chauvin P., Rouabhia M. (2004). Involvement of interleukin-18 in the inflammatory response against oropharyngeal candidiasis. Med Sci Monit 10: BR239 - BR249.
103. Taylor PR, Brown GD, Reid DM, Willment JA, Martinez-Pomares L., Gordon S., et al. (2002). The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol 169: 3876-3882.
104. Taylor PR, Brown GD, Herre J., Williams DL, Willment JA, Gordon S. (2004). The role of SIGNR1 and the beta-glucan receptor (dectin-1) in the nonopsonic recognition of yeast by specific macrophages. J Immunol 172: 1157-1162.
105. Taylor PR, Gordon S., Martinez-Pomares L. (2005 a). The mannose receptor: linking homeostasis and immunity through sugar recognition. Trends Immunol 26: 104-110.
106. Taylor PR, Martinez-Pomares L., Stacey M., Lin H., Brown GD, Gordon S. (2005 b). Macrophage receptors and immune recognition. Annu Rev Immunol 23: 901-944.
107. Taylor PR, Reid DM, Heinsbroek SE, Brown GD, Gordon S., Wong SY (2005 c). Dectin-2 is predominantly myeloid restricted and exhibits unique activation-dependent expression on maturing inflammatory monocytes elicited in vivo. Eur J Immunol 35: 2163-2174.
108. Taylor PR, Tsoni S., Willment J., Dennehy KM, Rosas M., Findon H., et al. (2007). Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 8: 31-38.
109. Torosantucci A., Chiani P., Bromuro C., De Bernardis F., Palma AS, Liu Y., et al. (2009). Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS ONE 4: e5392.
110. Turner J., Cho Y., Dinh NN, Waring AJ, Lehrer RI (1998). Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 42: 2206-2214.
111. Uehara A., Takada H. (2008). Synergism between TLRs and NOD1/2 in oral epithelial cells. J Dent Res 87: 682-686.
112. Uehara A., Sugawara Y., Kurata S., Fujimoto Y., Fukase K., Kusumoto S., et al. (2005). Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via Toll-like receptors, NOD1 and NOD2 in human oral epithelial cells. Cell Microbiol 7: 675-686. (Pubitemid 40585009)
113. Uehara A., Fujimoto Y., Fukase K., Takada H. (2007). Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol 44: 3100-3111.
114. Underhill DM, Rossnagle E., Lowell CA, Simmons RM (2005). Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 106: 2543-2550.
115. van de Veerdonk FL, Netea MG, Jansen TJ, Jacobs L., Verschueren I., Van der Meer JW, et al. (2008). Redundant role of TLR9 for anti-Candida host defense. Immunobiology 213: 613-620.
116. van de Veerdonk FL, Joosten LA, Devesa I., Mora-Montes HM, Kanneganti TD, Dinarello CA, et al. (2009 a). Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1beta production by the fungal pathogen Candida albicans. J Infect Dis 199: 1087-1096 ; erratum in J Infect Dis 199: 1716, 2009.
117. van de Veerdonk FL, Marijnissen RJ, Kullberg BJ, Koenen HJ, Cheng SC, Joosten I., et al. (2009b). The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 5: 329-340.
118. van der Graaf CA, Netea MG, Franke B., Girardin SE, Van der Meer JW, Kullberg BJ (2006). Nucleotide oligomerization domain 2 (Nod2) is not involved in the pattern recognition of Candida albicans. Clin Vaccine Immunol 13: 423-425.
119. Vignali DA, Collison L., Workman C. (2008). How regulatory T cells work. Nat Rev Immunol 8: 523-532.
120. Vylkova S., Li XS, Berner JC, Edgerton M. (2006). Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides. Antimicrob Agents Chemother 50: 324-331.
121. Weindl G., Naglik JR, Kaesler S., Biedermann T., Hube B., Korting HC, et al. (2007). Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest 117: 3664-3672.
122. Wells CA, Salvage-Jones JA, Li X., Hitchens K., Butcher S., Murray RZ, et al. (2008). The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J Immunol 180: 7404-7413.
123. Willment JA, Brown GD (2008). C-type lectin receptors in antifungal immunity. Trends Microbiol 16: 27-32.
124. Wilson D., Thewes S., Zakikhany K., Fradin C., Albrecht A., Almeida R., et al. (2009). Identifying infection-associated genes of Candida albicans in the postgenomic era. FEMS Yeast Res 9: 688-700.
125. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., Sabat R. (2004). IL-22 increases the innate immunity of tissues. Immunity 21: 241-254.
126. Xie MH, Aggarwal S., Ho WH, Foster J., Zhang Z., Stinson J., et al. (2000). Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 275: 31335-31339.
127. Zelante T., De Luca A., Bonifazi P., Montagnoli C., Bozza S., Moretti S., et al. (2007). IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37: 2695-2706.
128. Zelensky AN, Gready JE (2005). The C-type lectin-like domain superfamily. Febs J 272: 6179-6217.
129. Zhang J., Zhu J., Imrich A., Cushion M., Kinane TB, Koziel H. (2004). Pneumocystis activates human alveolar macrophage NF-kappaB signaling through mannose receptors. Infect Immun 72: 3147-3160.
130. Zhang J., Tachado SD, Patel N., Zhu J., Imrich A., Manfruelli P., et al. (2005). Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro. J Leukoc Biol 78: 665-674.
131. Zhou M., Yang B., Ma R., Wu C. (2008). Memory Th-17 cells specific for C. albicans are persistent in human peripheral blood. Immunol Lett 118: 72-81.